ID: ALA3276815

Max Phase: Preclinical

Molecular Formula: C20H25N3O

Molecular Weight: 323.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(CN(C)C)N1CCN(c2ccccc2)c2ccccc2C1=O

Standard InChI:  InChI=1S/C20H25N3O/c1-16(15-21(2)3)22-13-14-23(17-9-5-4-6-10-17)19-12-8-7-11-18(19)20(22)24/h4-12,16H,13-15H2,1-3H3

Standard InChI Key:  WXTJBKDLQKUHJN-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ileum 856 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 323.44Molecular Weight (Monoisotopic): 323.1998AlogP: 3.23#Rotatable Bonds: 4
Polar Surface Area: 26.79Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.71CX LogP: 3.20CX LogD: 1.87
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.86Np Likeness Score: -0.90

References

1. Bagolini C, de Witt P, Pacifici L, Ramacci MT..  (1978)  Synthesis and pharmacological activity and some derivatives of 1-phenyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one.,  21  (5): [PMID:26804] [10.1021/jm00203a015]

Source